Pathological stage in the untreated and treated patients with clinical stage B disease
| Pathological stage | Surgery only (%) | 12 weeks of NHT (%) | 24 weeks of NHT (%) |
|---|---|---|---|
| Chi square=13.124; p=0.041. Untreated versus 12 weeks of NHT: χ2=5.311; p=0.199 (not significant (NS)). Untreated versus 24 weeks of NHT: χ2=11.984; p=0.009. 12 weeks of NHT versus 24 weeks of NHT: χ2=2.526; p=0.641 (NS). | |||
| NHT, neoadjuvant hormonal treatment. | |||
| B | 40 (40.4%) | 59 (54.6%) | 59 (64.8%) |
| C1 | 45 (45.5%) | 33 (30.6%) | 23 (25.3%) |
| C2 | 9 (9.1%) | 11 (10.2%) | 7 (7.7%) |
| D1 | 5 (5.0%) | 5 (4.6%) | 2 (2.2%) |
| Total | 99 | 108 | 91 |